SUMMARY
Health professionals are increasingly asked to justify the allocation of scarce financial resources. Health "politicians" have to advise Treasury of appropriate budget allocations, area health administrators must determine how best the money can be spent to adequately meet community needs, and hospital administrators must continually balance the actual need for resources against ambitious aspirations of individual departments and services. Clinicians, who for so long have remained oblivious to such considerations, are being asked to justify clinical decisions in terms of cost-efficiency.
Intensive Care Units (ICUs) are among the most expensive areas of hospital activity and are, therefore, likely to come under increased scrutiny. The concept of Intensive Care as a separate and discrete specialty arose from the management of polio victims with longterm ventilation. Larsen and others demonstrated that the outcome of these patients was markedly improved as a result of their management in an intensive care environment. I From these origins, ICVs have grown in number so that most hospitals of greater than 250 beds have at least one. 2 The demand for these units has arisen from public expectation that everything possible be done for their loved ones, and a perceived logic that it is more efficient to treat the critically ill in one area.
The justification for this resource allocation has been questioned on the basis that a large proportion of intensive care resources are utilised on patients with poor outcomes, and in the monitoring and observation of low-risk patients who require little or no intervention. Oye and Bellamy found in their analysis of 404 admissions to an adult ICU that the small number ·F.R.A.C.P., Staff Specialist in Intensive Care.
Accepted for publication on October 5, 1993. (8%) of high-cost patients used as much of the resources as the large number (92%) of low-cost patients. Furthermore, 700/0 of the high-cost admissions died during that admission. 3 Knaus et al. found that 24% of 5,000 admissions to 14 adult ICVs required only close observation.' Thibault et al. noted that 77% of admissions to an adult medical coronary care unit were for monitoring only.' These observations were supported by reports demonstrating inverse relationship between the costs of and outcome from intensive care.
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No-one has proven that intensive care improves outcome. Unfortunately, the opportunity to demonstrate this in a prospective fashion would now be unacceptable, as treatment of various conditions in an ICV is now considered as standard for good medical practice. 11 Traditional management concepts suggest that, in assessing effectiveness, one needs to analyse actual outcome against input. Cost-effectiveness is derived when the actual cost of this process can be accounted for. 12 However, defining input, outcome, process and cost in the ICV is a complex matter. At the most basic level, patients at presentation represent the input and their status at discharge is the outcome. Process refers to the resources used in treating patients. These resources include buildings, equipment, drugs, disposables and salaries. Cost is the total expense of the system minus any income that may be derived ( Figure I ).
The biggest challenge in evaluation of intensive care is to maintain a global perspective of all these elements. Most ICU scoring systems relate some form of admission baseline data on a patient, to derive a probability of survival at hospital discharge. The flaw in these systems is not their meticulous use of baseline data to categorise the severity of illness, but that survival at hospital discharge is the only outcome assessed and does not take into account the true personal and social impact of the disease. 13 Moreover, only crude costing estimates have been employed to measure effectiveness. This review will discuss some of the more common ICU scoring systems. It will then outline some of the methods used to quantify outcome and finally discuss some of the studies that have tried to evaluate the cost of ICU practice.
THE IDEAL SCORING SYSTEM
The ideal system would utilise common and relevant data that is easy to measure and record. This data would be used to calculate severity of illness in a form which could be used in all patients with any illness. This calculation would not only give a survival probability, but would also predict quality of life, life expectancy and expected complications. A costeffective measure for each intervention on each individual patient would be derived from the above factors. This system would have in place a method for continually updating its database to allow a more accurate prediction of not only patient groups, but also individual patients, in the face of improving treatment practices or changing disease patterns.
A standardised system would allow an analysis of not only individual unit performance, but accurate comparison with other ICUs. CLASSIFICATION OF SCORING SYSTEMS Prediction of patient outcome involves collection of baseline data on patients and their illness and application of a statistical model to derive a probability of survival or mortality. 14 Most scoring systems classify a particular disease according to either anatomical involvement or physiological disturbance. Examples of the former include Duke's Classification for bowel cancer and the more generally applicable tumour, node, metastasis system (TNM) that is applied to many malignancies. Some trauma-scoring systems fall into this category, where illness severity is classified according to severity and extent of injury, as in the Injury Severity Score and the Abbreviated Injury Scale!S-19 The second category of scoring systems classifies the injury or disease according to the degree of physiological disturbance. An example of this is the Glasgow Coma Scale (GCS), which classifies severity of coma based on the presence or absence of three parameters, eye opening, verbal and motor responses to painful stimuli. 2o . 21 There are numerous other scoring systems based on physiological disturbance (Thble 2), but only those that relate to critically ill patients will be discussed in this review. These include the Acute Physiology and Chronic Health Evaluation (APACHE), the Physiological Stability Index (PSI), Mortality Prediction Model (MPM) and the Paediatric Risk of Mortality Score (PRISM).
APACHE
The Acute Physiology and Chronic Health Evaluation (APACHE) developed by Knaus and colleagues at the George Washington University Medical Center (GWUMC) is the most commonly utilised physiologically based scoring system. This system obtains extra predictive power by incorporating weighting for age, chronic illness and operative status. APACHE has evolved over two decades and is now in its third revision, with a literature full of validations and criticisms. Importantly, it has provided an acceptable system of classifying ICU patients. Before reviewing the literature on APACHE, it is important to state from the outset that the motivation for the development of APACHE was to provide a system of severity of illness that accurately described groups of ICU patients, thus allowing evaluation of the outcome of these groups. Because of APACHE's validation within patient groups, various authors have attempted to extend its predictive power to individual patients, a purpose for which it was not designed.
The original APACHE classification, or APACHE I, had two components: a physiology score, representing the degree of acute illness, and a chronic health evaluation. The acute physiology score comprised 34 different variables from the body's seven major organ systems. Each variable was given a score from 0-4, depending on the degree of abnormality present, 0 representing a normal value and 4 representing the most severe abnormality. For example, a heart rate of 70 to 109 scored 0, and heart rates of ~ 180 and :5 39 score 4. The sum of scores for each of the 34 variables was totalled to obtain an acute physiology score. If a variable was not measured it was assumed to be normal and given a score of O. The initial 34 variables were chosen by two of the original authors, Knaus and Zimmerman, after a literature review which revealed physiological disturbances that demonstrated promise in estimating severity of illness, and that were measured in most ICUs. They also allocated the weightings within the range of 1 to 4 for each abnormal variable. Five critical care physicians of varying backgrounds and experience were invited to analyse the scoring system and designate alternative weightings to each of the 34 variables, and to list additional variables which might require consideration. Some variables were considered not to be as significant as others and, therefore, maximal derangement could only be scored as 1 or 2 points. The degree of variance among the seven physicians who derived the initial APACHE was not measured.
The second component of APACHE I, chronic health evaluation, was derived from the patient's medical history in the three to six months prior to admission. This classification divided patients into four categories, ranging from category A, where patients had prior good health, with no functional limitations, to category D, where patients were severely restricted due to chronic disease.
APACHE I was validated in a number of situations, with alterations being made to the scoring system until the now commonly used APACHE II was produced.
Firstly, Knaus classified 582 ICU admissions to GWUMC over an eight-month period, along with 223 consecutive ICU admissions to a community hospital.
The only exclusions were patients with burns, acute mycocardial infarction, or those admitted for less than 16 hours. Admission APS score taking the most abnormal variable in the first 32 hours was correlated with the therapeutic intervention scoring system (TlSS) and outcome status (i.e. alive or dead) upon ICU discharge, hospital discharge, and six months after hospital discharge. Analysis revealed a strong correlation between increasing APS and probability of hospital mortality, both for the teaching-hospital group 21.
(r = 0.51, P = 0.01) and the community hospital group'O (r = 0.47, P = 0.01). As expected, there was also a strong correlation between an increasing APS and the TlSS score. The chronic health evaluation also demonstrated increased mortality for the most debilitated patients (groups C and D), with non-operative cases in all four chronic health groups having increased mortality. However, using the decision criteria for death as a probability of 0.50, for individual patients, 52 patients who were predicted to live, died. More importantly, 13 patients predicted to die actually lived.
This resulted in a false-negative rate of 21 % and a falsepositive rate of 10070. The limitations of APACHE for individual prognostication were, therefore, recognised by Knaus et al. from the outset. 22 Multi-institutional validation of APACHE I was undertaken by contrasting mortality for groups of ICU patients in five different institutions. 21 In this study, minor alterations were made. Serum osmolality was deleted from the initial collection of 34 variables that made up the APS, as it was not a consistently measured variable and, when measured, did not add any additional explanatory power to the APS. Rather than the initial data collection time of 32 hours, data was collected as the worst abnormality in the first 24 hours following admission.
Using GWUMC data, a logistic multiple regression equation was derived where age, sex, operative status, admission organ system failure and APACHE I score were the independent variables and outcome was the dependent variable. The general equation derived was: log (R/I-R) = A + BiXi where R is the risk of death, A is an estimated constant term, Xi is the summed value of independent variables, and Bi the summed value of estimated regression coefficients. Using this equation derived from GWUMC data, mortality was then predicted in the five study hospitals. A predicted group death rate for each institution was calculated by adding the individual risk of death of each admission according to the above equation, summing all these values, and finally dividing them by the total number of admissions. Despite large variations in admission APS, predicted group hospital death rates correlated closely with actual deaths. Furthermore, within the Anaesthesia and Intensive Care, Vol. 22 , No. I, February, 1994 logistic mUltiple regression equation the most significant variable was the APS of the APACHE I classification.
This study was extended to compare the data from 12 hospitals in France, where once again patients were grouped by APACHE score. 24 Predicted outcome correlated with the actual outcome. There was one exception in the category of gastrointestinal disorders, where the French were having worse than expected results from their aggressive surgical approach to pancreatitis.
From these early studies, the data was retrospectively analysed, and the APS simplified into what became known as APACHE 11. 25 The major change was reduction of the initial 34 physiological measurements to 12, still reflecting derangement for all major organ systems, while maintaining explanatory power. Each measurement was initially deleted on clinical grounds, and the then revised APS was validated using a multivariate comparison with the original APACHE I system. Some of the thresholds and weightings within the APS were then adjusted. Retrospective analysis revealed that the Glasgow Coma Score, the only central nervous system variable, should be more heavily weighted. Also, an elevated creatinine in the presence of acute renal failure was found to be of considerable prognostic importance. The weighting for creatinine in acute renal failure was, therefore, doubled. Finally, a direct weighting was developed for all Pa02 values when Fi02 was less than 0.5. Unlike the original APACHE I, where unmeasured variables were assumed to be normal, it was felt by the authors, that with the new simplified APS, all values should be measured.
The chronic health evaluation component of APACHE was changed to incorporate the welldocumented fact that increasing age was in itself a potent predictor of death, independent of disease and physiological derangement. Finally, it was revealed that severe chronic organ failure and immunosuppression markedly and independently influenced outcome. The chronic health evaluation was, therefore, altered to give a score for age, a score for severe chronic organ failure or immunosuppression and a score for operative status, acute procedures weighting more than elective procedures. This gave an APACHE with a score range of 0-71.
APACHE 11 was then evaluated in a comparative study of 13 major US Medical Centres. 26 This was done in similar fashion to the previous evaluative studies, whereby the modified APACHE score was used in the multiple logistic equation along with a weighting for admission disease classification, and then predicted hospital mortality was compared with that actually observed. While demographic data were similar at all 13 institutions, of 5, 030 patients admitted into the study 1, 657 were contributed by one institution. Furthermore, the institutions selected themselves for the study by a willingness to co-operate with the study as outlined by the authors. The results were revealing, with one hospital achieving a significantly better (P < 0.001) than predicted death rate by 41070. At the other extreme, one hospital achieved a significantly worse death rate than predicted by 58070. While all the units in the study had similar case mixes, and utilisation of technology, it was in the administrative structure of the units that significant differences were found. The best-performing hospital had excellent communication between physicians and nursing staff that extended to education programmes, clinical protocols, and admission/discharge policy. At the other extreme, the worst-performing hospital functioned without comprehensive nursing systems, there was no full-time director, and poor communication between nursing and medical staff existed.
With APACHE 11 thus validated, it was used to classify ICV patients for research purposes,>7-33 to compare differences in intensive care practices, 23,24,34,3 5 to standardise clinical audit,36,37 not only for retropective quality assurance but also for prospective evaluation. 3 With the increasing utilisation of APACHE 11, some limitations and deficiencies became apparent. There is an inherent false classification rate of approximately 10-15% with any predictive system.4I This is often brought about by the fact that unpredictable and unique events contribute to mortality in the intensive care population. As yet, no system has sufficient ability to predict, for example, unexpected myocardial infarction, idiosyncratic drug and blood reactions, or fatal pulmonary emboli. Conversely, we all have anecdotal examples of patients with an apparently hopeless outcome, who, with a combination of modern technology, good care, and good fortune, have survived ICV to remain useful citizens. One of APACHE lI's major limitations was the effect of medical management prior to initial calculation of the APACHE 11 score on ICV admission: 2 How does one define when ICV management commences? Patients can suffer severe multi-system trauma and their admission APACHEs can vary considerably, depending on the quality of care received before ICV admission, and yet still have a similar eventual outcome. The same situation applies to the many postoperative patients where anaesthetic management is important. Another major deficiency of APACHE 11 is that there are some disorders (e.g. diabetic ketoacidosis) that have a severe physiological disturbance, but an almost universally favourable outcome. Specific analysis of grouped APACHE 11 scores as a tool for cost containment and quality assurance by Civetta et al. revealed no correlation with total hospital charges, nor mortality rates for surgical ICV patients: 3
Some authors have attempted to refine the science of predicting patient outcome by utilising a daily APACHE calculation. 44 · 46 The concept of dynamic daily organ failure analysis to increase the predictive power of the previously static APACHE 11 score has been studied by Chang from Riyadh.47 By using this method, and introducing another outcome group of "outcome unknown", 181 of 722 patients died. There were no false predictions of death. The obvious advantage of such a system is that patients in the group "outcome unknown" would still receive maximal therapy, whereas, with the prediction of death, the clinician would have statistical evidence to help support a clinical decision to withdraw therapy.
Some of the limitations of APACHE 11 have been addressed by Knaus meet statistical criteria for independently contributing explanatory power to the APACHE Il score. However, analysis of different weightings revealed increased explanatory power was obtained when additional weight was assigned to extremes of physiological measurement and when a narrower range was assigned zero or normal weightings. Measures for some variables had different weightings assigned for equally extreme but diametrically opposite recordings. For example, severe hypotension had greater predictive power for mortality than extreme hypertension. Further, explanatory power was increased when the following interactions were accounted for: serum pH with PCOl, serum creatinine with urine output and respiratory rate with ventilator use. Reformatting the GCS to eliminate similar scores with different clinical presentations also gave better explanatory power. The worst value for each physiological variable within the first 24 hours of ICU admission was used. Thus, the new APACHE III APS score has a range from 0 to 252. Having developed these variables and weights, APACHE III was validated by using it to predict outcome in the second half of the database. In this population, APACHE III had excellent positive predictive value of 0.88.
In developing the APACHE III predictive equation, weightings were derived from 78 diagnostic categories by analysing the entire database. Analysis of 34 candidate chronic health items in this database revealed seven that had significant explanatory power: acquired immunodeficiency syndrome, hepatic failure, lymphoma, metastatic cancer, leukaemia/multiple myeloma, immunosuppression and cirrhosis. However, there was no significant additive explanatory power when these patients underwent elective surgery.
Finally, the weightings for age were expanded. The APACHE III score then consisted of a score in the range of 0 to 299; the APS component being 0 to 252, chronic health evaluation 0 to 23, and age 0 to 24. The mean APACHE III in the database was 50. A further innovation of APACHE Ill, which may help to predict hospital mortality, has been to account for the various ways in which the different components of the APACHE score may interact. For example, when the APACHE III score is either low (::;; 20) or high (~ 140), the relative importance of disease type is small. However, in the mid-range of APACHE III scores disease classification becomes a more potent predictor of outcome. Vse of latest day and initial APACHE III score was found to have better explanatory power than initial APACHE III score alone. Analysis of their data also revealed a marginally increased mortality in association with ICV readmission, ward or hospital transfers, compared with direct admissions from the emergency room.
Comparison of the predictive ability of APACHE III with APACHE 11 and the Mortality Prediction Model (MPM) was favourable. Taking 0.5 as the point at which mortality is predicted, and using initial day scores, APACHE III had a correct classification rate of 88.1070 compared with 79.1070 for the MPM. Physician judgement has been estimated at between 84070 to 89070. 49 Despite nearly two decades of research on thousands of ICV patient admissions, the APACHE system fails to answer the question of whether a given critically ill patient will live or die. Although comparing favourably with APACHE 11 and other scoring systems, APACHE III is still only a marginally better predictor of ICV outcome than physician judgement alone (correct classification rate of 88.1070 vs 84070-89070). 49 The creation of a third outcome category, "outcome unknown", and using computerised analysis of daily APACHE, has improved the predictive power of APACHE. Most of the false negatives and false positives fall into this category. This, after all, models what instinctively the intensivist knows: that, if after 48 hours, a critically ill patient is not improving, or even deteriorating, the outcome is poor.
APACHE scores fulfill Knaus' initial aim of accurately predicting outcomes for patient groups with different illness status presenting to the ICV. This information is valuable for research, quality assurance and unit management.
OTHER ICV SCORING SYSTEMS
APACHE is not the only outcome-predictive scoring system for intensive care. Le Gall et al., in 1984, introduced a Simplified Acute Physiology Score (SAPS), which was a less complex and time-consuming system. so This system was validated in 679 consecutive admissions, and it was found to compare favourably with acute physiological scores derived from APACHE 11.
The MPM, as described by Lemeshow and Teres, adopted a different approach to predicting patient outcome.
SI They developed a number of objectively derived variables, compared with the subjectively derived APACHE 11 system, in order to predict outcome based on a multiple logistic regression model.
The model was developed by collecting up to 137 admission variables relating to past medical history, patient condition, and treatment on 755 consecutive ICV admissions to Baystate Medical Center in 1983. Another 75 variables relating to patient condition and treatment at both 24 and 48 hours were collected. In addition, variables relating to length of stay, ICV and hospital discharge status were collected to give a total of 377 possible variables. Tests of association to status at hospital discharge were then performed for each of these variables. This process revealed 26 possible condition variables at admission, and 44 possible 24-hour treatment and condition variables that correlated with hospital discharge status. Application of the multiple logistic regression model to these variables concluded that seven variables were significant predictors of patient status at hospital discharge. The most powerful predictor of outcomes was the presence of coma or deep stupor at ICV admission. The correct classification rate of the MPM was 87070 at admission and 85070 at 24 hours, compared with 81070 accuracy for APS.
The MPM was further validated in 1987 by the original authors in an analysis of 1,997 consecutive ICV admissions, in a study population different from that used to develop the model. Analysis revealed that the admission model had excellent goodness of fit, correct REVIEW classification rate, sensitivity and specificity. However, the 24 hours post-ICU admission model did not fulfill the above criteria. 52 This same cohort was utilised to compare MPM with APS and the SAPS, with respect to sensitivity, specificity and total correct classification rate. Analysis revealed that the APS overestimated and the SAPS underestimated the probability of hospital mortality; the MPM obtained the best goodness of fit for prediction of hospital mortality. 53 Not surprisingly, the authors felt that the MPM had a number of advantages, namely, its use of seven easily obtained variables on admission to create an objective probability of survival.
In 1988 the MPM was further refined, obtaining improved predictive power by developing a model which incorporated the analysis of serial observations of the seven admission variables at 24 and 48 hours.'4 The change in probability from each assessment was also incorporated as an independent variable. The Glasgow Coma Score (GCS), which is a substantial and potent variable in APACHE, SAPS and MPM alone, has powerful predictive value in some patient groups." In a Finnish multicenter study of 619 post-cardiac arrest patients, using data collected 24 hours post-admission, the GCS had a positive predictive value for death of 76.5070 compared with 82.9% for APACHE 11. The authors concluded that the GCS contributed a substantial proportion of the predictive power of APACHE 11 in the patients. 
PAEDIATRIC ICU SCORING SYSTEMS
The scoring systems discussed to date have had some important patient group exclusion criteria, notably burns, and acute myocardial infarction victims. Another important exclusion from analysis has been the paediatric population. This deficiency has been addressed by Pollack and co-workers from Washington, with the development of the Paediatric Risk of Mortality Score (PRISM).56 This score was developed from the Physiologic Stability Index (PSI), which has proven validity for assessing risk of mortality.57-60 The PSI comprised 34 variables and 75 predefined abnormal variable ranges, with derangements scoring either 1,3 or 5, depending on severity. Once again, it was the desire to create a simpler, more user-friendly system with powerful predictive value that led to the development of the PRISM score by reducing the number of physiological variables to 14.
The performance of the PRISM score, using a logistic function equation to estimate mortality, was analysed in 1,227 patients from six different paediatric intensive care units. This analysis revealed a strong correlation between increasing PRISM and risk of mortality. 6 1 PRISM has subsequently been used to cost-stratify paediatric intensive care populations and to compare different units' casemix and patient outcome. 62 -65
QUALITY OF ADJUSTED LIFE YEARS AS A MEASURE OF ICU OUTCOME
The major limitation of APACHE, and the previously described scoring systems, is that the outcome measure is simply survival or death at hospital discharge. These systems fail to account for length of survival post-ICU treatment and the quality of life of that survival.
Although measurement of length of survival post-ICU treatment is objective, devising a scale for quality of life is largely a subjective exercise. An important consideration is, who judges what constitutes quality of life-the physician, the patient or others such as care-givers?66 For example, resuscitating a young trauma victim, treating his/her multi-organ failure, and managing other complications, and discharging the patient alive from hospital, may be seen as a great ICU success. However, if that patient has tracheal stenosis, suffers recurrent nightmares and continual neurogenic pain, is this such a success?
Various techniques for measuring quality of life have been devised, with the aim of objectively comparing treatment with no treatment and different treatment modalities against each other. These scales, for example, attempt to place a value on coronary artery bypass surgery either compared with no surgery or to another treatment in a different patient population, for example, hip replacements in arthritic patients.
A number of quality-of-life measures may be potentially useful as tools for measuring ICU outcome. For any measure to be clinically significant, it must have three attributes: reproducibility, validity and responsiveness. A measure is "reproducible" if the same result is achieved after repeated measurements on stable patients. "Validity" infers that the instrument measures what it is supposed to measure. 67 -69 Validity implies that there is some gold standard against which the particular measurement can be compared. Herein lies the essential problem of measuring quality of life: just what is quality of life? Finally, the measurement instrument must be "responsive" to any change in the measurement, to enable it to detect the effect of any intervention. 70 Scales for measuring quality of life have been divided into two categories, generic and specific (Table 7) .71 Specific scales focus on one particular aspect of quality of life that is relevant to a particular disease, an intervention, or possibly both. 69 Unfortunately, with the myriad of illness and disease, and interventions that occur with intensive care management, specific scales do not lend themselves to the analysis of post-ICU quality-of-life assessment. Generic instruments attempt to quantitate the complete spectrum of function, disability and distress that relates to quality of life and therefore achieve a more accurate picture of outcome. Generic instruments can be further divided into healthprofile measures and utility measures. HEALTH-PROFILE MEASURES "Health profiles" include the activity of daily living (ADL)'2 which derives a score based on ability to perform tasks such as bathing, dressing, movement about the house, continence and feeding. Another "health profile" is the sickness impact profile (SIP)'3,74 which measures behavioural change as a result of illness. This scores 12 different functions: sleep and rest, eating, work, hair management, recreation and pastimes, ambulation, mobility, body care and movement, social interaction, alertness, emotions and communication. One hundred and thirty-six objective, self-administered scores cover the 12 categories. The Nottingham Health Profile (NHP),75 derived mainly from the sickness impact profile, is another selfassessed measure of perceived physical, social and emotional health.
The main advantage of health profiles is that they are generally applicable for different interventions on different patient populations. However, they can suffer from a lack of sensitivity in detecting alterations of quality of life that may occur as a result of a specific intervention. 76, 77 
UTILITY MEASURES
Utility measures are derived from economic and decision theories that reflect patient preference for treatment processes and their relative outcomes. There are two traditional methods for deriving these scores. One method is to have patients make a single rating of their quality of life 78 and then ask them to perform a standard gamble. This gamble can either be the relative choice between death and complete well-being. Alternatively, the patient can perform a time trade-off: how much duration of life with their current state of quality of life would they sacrifice for a reduced amount of completely well time? However, neither of these gambling techniques takes any account of individual risk-aversion behaviour and the non-linear perception that most people have of time. 79 Health-profile scales, although describing a particular quality of life, do not place a value or score on quality-of-life status, thus making comparison of different states difficult. Utility measures, on the other hand, derive a score for a particular state of quality of life within the spectrum of being completely well, with no distress, and quality of life that is, in fact, perceived to be worse than death itself. It is important for any objective evaluation of outcome that it is expressed in a single score.
The utility method involves the creation of a scale by patients numerically comparing various quality of lives. The Rosser index, derived in 1978, asked six groups of subjects to numerically rate 29 different ranked sickness states. 79 The sickness states were obtained by crossing eight states of increasing disabilities with four states of distress, varying from no distress to severe distress. The six groups of subjects included patients with different experiences of illness: medical and psychiatric patients, medical and psychiatric nurses, experienced doctors and healthy volunteers. A ratio scale of the various illness states was obtained with a range of one (no pain, no distress) to -1472 (maximum pain, maximum distress). It should be noted that the psychiatric patients had disproportionately high negative scores for the more severe sickness states than the other five groups of subjects. Each different state of quality of life can be assigned a numerical value of between 1.0 for being completely well and 0.0 for death.
The main advantage of utility scales is that they can be utilised, along with expected survival, to calculate a quality of life adjusted year for a particular patient. The quality of life adjusted year (QALY) can be used to measure the impact of any health care intervention in two dimensions: length of life and quality of life. 80 ,81 For example, a 60-year-old with severe arthritis of the hip has a normal life expectancy of another 20 years. However, because this patient rates his/her quality of life at 0.5, the resultant QALY is 10 (0.5 X 20 years = 10 years). If the patient then undergoes a hip replacement that improves their quality of life to 90070 of normal, then eight QALYs have been gained ([0.9 -0.5] x 20 years). The cost of hip replacement can then be compared with the QALYs gained. 82 The major advantage of this system of costeffectiveness analysis is that it allows comparisons between vastly different treatments and interventions. QALYs have been used in the economic justification of various treatment modalities. 83 The major concerns about the utilisation of QALYs relate mostly to the validity and applicability of the particular utility scale that is incorporated to calculate a particular QALY. Arbitrarily, utility scales are applied to the particular population that suffers from a particular health state and would benefit from interventions applicable to that health state."2 However, the value one places on a particular quality of life is influenced by the perspective of the observer. 79 Initial assumptions that, by using the patient's own assessment of their quality of life, there would be an overestimate of their status in an attempt to gain priority for treatment of their condition, have proven to be unfounded. 84 In fact, the converse applies as patients adapt to the quality of life of their own sickness state. 85 A study of quality of life post-intensive care treatment found no correlation between patients' actual functional status and their perceived quality of life."6 It was suggested that patients who have undergone critical illness tend to rationalise their experience, and view their disability in a positive way.
One of the major deficits in using QALYs to measure outcome and effectiveness is that there is often inadequate knowledge of the benefit or otherwise of particular interventions, on both duration of life and quality of life. This is, in fact, not so much a deficit of QALY utilisations, as an ignorance of the way we apply treatments and interventions.
Finally, utilisation of QALYs has been criticised because they have inherent bias against the elderly on two accounts. Firstly, the elderly tend to have greater disabilities and, secondly, they have a lower predicted survival. 87 -89 However, it may be discriminatory to assume that the elderly, even with greater disability, have a lesser quality of life than younger members of the community.
The major advantage of QALYs is that they provide a single score that allows relative comparisons based on marginal differences between various life states and interventions. In other words, because the elderly have greater disabilities they also have greater potential for improvement with intervention.
Secondly, QALYs are a vast improvement on previous cost-effectiveness scales, which did not take into account morbidity but only analysed measures of survival. 82 In contrast with the wide utilisation of scoring systems such as APACHE that measure severity of illness on admission to predict an in-hospital survival, there is a paucity of studies that analyse the long-term benefits of intensive care, both in terms of survival and quality of life. Zaren and Hedstrand in 1978/° using a modified outcome scale to assess quality of life, analysed 717 survivors of their multidisciplinary ICV one year after their admission. The results revealed that 87070 of these patients returned home to live; that 80% of patients aged 65 years or greater were living independently post-ICV compared with 90% pre-ICV, and that, of those patients younger than 65, 65% returned to the work force. They found that patients who needed ventilation, or greater than a one-week admission to the ICV, fared worse at their one-year analysis. They concluded that ICV intervention did not greatly reduce survivors' quality of life.
A study of 313 patients in 1988 assessed early and late mortality as well as quality of life in 118 long-term survivors. 9' The survival rate at discharge from ICV was 76%, falling to 61 % at six months and to 58% at one year. Quality of life was assessed at two years by documenting information on housing, drug use, hospital admissions, physical condition and functional status. There was no change in living circumstances but drug use and the number of hospital admissions were significantly increased. Compared with their physical status prior to intensive care, 21% of patients deteriorated significantly, while 77% remain unchanged, and 2% improved. Major functional impairment was found in 38%. Predictors of post-I CV quality of life were, most importantly, prior health status and, to a lesser extent, simplified acute physiology score and age on ICV admission.
A New Zealand analysis 92 of 300 consecutive ICV admissions found a two-year survival of 74%. Good quality of life was present in 74% of survivors, with 19% having a lessened quality of life, and 7% being severely restricted.
Dragsted et al.,93 from Copenhagen, made an important contribution to our knowledge of long-term survival of intensive care, with a study of patients five years' post-I CV admission. Of the 1,308 consecutive ICV admissions, 926 were discharged from hospital alive, and 58% survived to five years. Not surprisingly, the most important factor for long-term survival was a history of cancer at the time of ICV admission. Other significant factors were age, and a medical diagnosis in contrast to a surgical one.
Quality of life was assessed in another group of 126 patients post-ICV by using the Karnofsky index for physical activity.94 A linear analogue self-assessment (LASA) was subjectively applied to variables such as general feeling of well-being, pain, appetite, anxiety and the patient's perception of treatment response. The quality of life of patients who survived longer than six months was high in this group, and unimpaired when compared with their ratings before admission. Furthermore, patients with relatively better quality of life before ICV admission maintained this quality of life despite ICV treatment.
In contrast to these findings, Ridley and Wallace,95 from the Western Infirmary, Glasgow, in 1990 documented that patients with a good premorbid quality of life suffered a significant decline after critical illness. They also found significant decreases in quality of life in younger patients and trauma victims. However, the average demographics of their patient population is not stated, and it is therefore difficult to compare these results with other studies.
Kerridge, from Australia, in work aimed primarily at developing methodology of using quality-of-life adjusted years, has developed a model to evaluate intensive care intervention outcome, and the relative economic justification of these interventions (Personal Communication). Two hundred and fifty consecutive ICV admissions, including those who died, were evaluated in various disease and interventional categories. After admission, survivors were assumed to have continued survival at 90% of their age-specific category. Morbidity was then discounted by determining quality of life according to Rosser utility categories by the application of the York health questionnaire. Next, relative survival ratios for each diagnostic category were obtained by the Delphi technique in order to score relative survival for each diagnostic category with either intensive care treatment, standard ward management, or no treatment at all. With this information, and using statistical models, it was possible to derive a cost per QALY for ICU intervention in various diagnostic categories. This allowed comparison within the same diagnostic category of no treatment or standard ward management of intensive care intervention.
Although the results must be regarded as highly tentative, certain patient groups could be identified (for example, in young trauma victims) where expensive intervention was economically justifiable. On the other hand, the economic justification for management of patients with end-stage cardiovascular disease, such as pulmonary oedema and peripheral vascular disease, was questionable.
There is an expanding literature on analysis of quality of life, little of which has been applied to the intensive care setting. The intensivist too often has focused on the simple outcome of alive or dead at ICU discharge. Economic and social pressures will contribute to the need to know more about long-term ICU survival, but also quality of life of that survival.
THE COST OF INTENSIVE CARE
Measurement of resource allocation in the ICU can either be determined directly in dollar terms or indirectly by measuring therapeutic interventions. The best example of the latter is the therapeutic intervention scoring system (TISS). 96, 97 TISS was initially developed to measure severity of illness and has subsequently found greater applicability as a measure of resource utilisation. The initial rationale for TISS was that sicker patients receive more investigations and interventions. However, as with any intervention-based measure, there can be large discrepancies between individual physicians, departments, hospitals and cultures. TISS has found value as a score which simply reflects the amount of intervention and investigation that a patient receives, and has therefore been utilised to analyse the performance of other ICU scoring systems. TISS scores have also been used to determine nursing workloads.
There are two ways that intensive care can be costed in dollar terms. In the first method, each patient is allocated a share of the fixed capital costs, such as buildings, equipment and electricity. To this one can add the cost per unit time for each intervention of various staff members from cleaners to consultants.
Charges for all auxiliary services such as pathology, pharmacy, administration and radiology must be comprehensive. Account of costs for maintenance, wastage and under-utilisation is also required.
A second and more simple way of deriving a cost for intensive care practice is simply to cost the whole annual budget and divide that cost by the number of bed days, possibly arbitrarily setting different cost levels for broadly different patient categories. It is, therefore, not surprising that there is a lack of consistent data of the cost of intensive care management.
In the United States, ICU costs account for approximately 100/0-21 % of hospital charges, this making up to 1% of the gross national produces However, extrapolation of these data to the Australasian scene may be irrelevant because of the differences between our medical systems and, in particular, intensive care utilisation practices. Zimmerman et al. in 1988 studied the differences between the 13 US hospital ICUs used to validate APACHE 11 and two New Zealand ICUs. 35 The New Zealand ICUs had younger, more severely ill patients, while up to 40% of ICU admissions to the US institutions were for monitoring elective surgical patients. Furthermore, on average the New Zealand hospitals studied had only 1.7% of beds assigned to critical care whereas the US institutions had 5.6%.
In the only major Australasian study, Slayter 99 costed 100 consecutive admissions to the Newcastle ICU and analysed the survivors' quality of life. TISS was used to classify severity of illness. Cost was determined at the clinical level, directly measuring clinical staff time (medical and nursing), diagnostic tests, disposables, drugs, IV fluids, physiotherapy, oxygen, light and power. Costs not included were the capital items, support services and administrative services. Mean cost per admission was AUD$I,357 (per day), but over 70% of patients had costs less than AUD$I,OOO (per day). Severity of illness was found to be a strong predictor of ICU cost. However, there was no association between cost of admission and resulting quality of life of survivors, using an index that rated occupation, activities of daily living, perception of own health, family and friend support, and outlook on life.
A New Zealand study92 of 300 consecutive admissions to ICU in 1983 estimated an average patient cost per day of NZ$I,507, derived from computer base estimates of hospital costs and budget allocations for the 1987-88 year. A further analysis in 1992 of 24 postcardiac surgery patients admitted in 1989 revealed an average cost of NZ$2,948 per patient for each admission, with an average stay of 37 hours. In this study, more detailed account was taken for all the components of this cost, including all fixed costs, variable costs and direct patient costs. lOO AUK studylOl accounted for direct clinical costs and derived a cost for auxiliary services, administrative and capital cost per patient. This study revealed an average patient cost per day of £653, increasing to £938 for those receiving renal replacement therapy. Using similar costing strategies, a study from Glasgow in 1991 revealed a range of cost from £399 per patient day for spontaneously breathing patients to £726 when ventilation was instituted. 102 Another AustralianstudylO3 revealed a mean cost per day of each of their patients of $1,200. Once again, direct cost estimates were used. The range of daily costs was $750 to $3,400, and, importantly, the patient's diagnostic-related group had little association with actual cost.
For such an expensive hospital activity, and in the current financial climate of cost containment, it is surprising that so little is known about the cost of intensive care management, and that comprehensive methods of cost measurement have not been developed.
CONCLUSION
The real question remains unanswered. Is intensive care cost-effective? If so, who does it benefit most? How much does it cost and would the money be better spent in another area of health or community need? These questions will be asked increasingly by government and society. To answer them we need to refine our scoring systems, extend and improve our measurements of outcome and accurately cost intensive care facilities.
